HealthEquity ROE 2014-2025 | HQY
Current and historical return on equity (ROE) values for HealthEquity (HQY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| HealthEquity ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-01-31 | $0.10B | $2.12B | 4.57% |
| 2024-10-31 | $0.10B | $2.13B | 4.61% |
| 2024-07-31 | $0.11B | $2.16B | 5.12% |
| 2024-04-30 | $0.08B | $2.10B | 4.01% |
| 2024-01-31 | $0.06B | $2.04B | 2.84% |
| 2023-10-31 | $0.03B | $1.99B | 1.55% |
| 2023-07-31 | $0.01B | $1.95B | 0.68% |
| 2023-04-30 | $-0.01B | $1.92B | -0.48% |
| 2023-01-31 | $-0.03B | $1.90B | -1.44% |
| 2022-10-31 | $-0.06B | $1.88B | -3.22% |
| 2022-07-31 | $-0.06B | $1.87B | -3.38% |
| 2022-04-30 | $-0.06B | $1.86B | -3.01% |
| 2022-01-31 | $-0.05B | $1.85B | -2.42% |
| 2021-10-31 | $-0.01B | $1.87B | -0.40% |
| 2021-07-31 | $0.00B | $1.86B | 0.00% |
| 2021-04-30 | $0.00B | $1.85B | 0.27% |
| 2021-01-31 | $0.01B | $1.38B | 0.70% |
| 2020-10-31 | $0.00B | $1.36B | 0.34% |
| 2020-07-31 | $-0.02B | $1.34B | -1.72% |
| 2020-04-30 | $0.00B | $1.04B | 0.00% |
| 2020-01-31 | $0.04B | $1.03B | 4.45% |
| 2019-10-31 | $0.05B | $1.02B | 6.97% |
| 2019-07-31 | $0.09B | $1.02B | 14.52% |
| 2019-04-30 | $0.09B | $0.53B | 19.83% |
| 2019-01-31 | $0.08B | $0.48B | 17.01% |
| 2018-10-31 | $0.07B | $0.46B | 16.66% |
| 2018-07-31 | $0.06B | $0.43B | 16.42% |
| 2018-04-30 | $0.06B | $0.40B | 16.08% |
| 2018-01-31 | $0.05B | $0.35B | 14.61% |
| 2017-10-31 | $0.05B | $0.33B | 14.96% |
| 2017-07-31 | $0.04B | $0.32B | 14.62% |
| 2017-04-30 | $0.03B | $0.29B | 12.25% |
| 2017-01-31 | $0.03B | $0.26B | 10.64% |
| 2016-10-31 | $0.03B | $0.25B | 10.89% |
| 2016-07-31 | $0.02B | $0.24B | 10.66% |
| 2016-04-30 | $0.02B | $0.22B | 9.33% |
| 2016-01-31 | $0.02B | $0.20B | 8.57% |
| 2015-10-31 | $0.02B | $0.20B | 9.88% |
| 2015-07-31 | $0.02B | $0.19B | 10.14% |
| 2015-04-30 | $0.01B | $0.16B | 12.42% |
| 2015-01-31 | $0.01B | $0.14B | 17.57% |
| 2014-07-31 | $0.01B | $0.01B | 254.55% |
| 2014-04-30 | $0.01B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.975B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $137.452B | 25.78 |
| Elevance Health (ELV) | United States | $85.620B | 11.05 |
| CVS Health (CVS) | United States | $80.443B | 10.00 |
| Cencora (COR) | United States | $56.509B | 19.66 |
| Natera (NTRA) | United States | $21.868B | 0.00 |
| DiDi Global (DIDIY) | China | $21.650B | 32.86 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| Solventum (SOLV) | United States | $12.848B | 13.60 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.645B | 0.00 |
| CochLear (CHEOY) | Australia | $11.378B | 0.00 |
| ICON (ICLR) | Ireland | $10.802B | 10.04 |
| Revvity (RVTY) | United States | $10.730B | 18.47 |
| Viatris (VTRS) | United States | $10.223B | 3.51 |
| Doximity (DOCS) | United States | $10.051B | 46.53 |
| Avantor (AVTR) | United States | $8.961B | 13.02 |
| Medpace Holdings (MEDP) | United States | $8.797B | 23.36 |
| Sonic Healthcare (SKHHY) | Australia | $8.301B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.802B | 13.33 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| BrightSpring Health Services (BTSG) | United States | $4.121B | 38.15 |
| Bausch + Lomb (BLCO) | Canada | $4.065B | 23.96 |
| Sotera Health (SHC) | United States | $3.486B | 19.81 |
| Alignment Healthcare (ALHC) | United States | $3.035B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.984B | 38.80 |
| Concentras Parent (CON) | United States | $2.776B | 16.04 |
| Organon (OGN) | United States | $2.454B | 2.61 |
| Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
| GeneDx Holdings (WGS) | United States | $2.078B | 80.01 |
| Premier (PINC) | United States | $1.899B | 14.41 |
| Progyny (PGNY) | United States | $1.884B | 41.47 |
| PACS (PACS) | United States | $1.554B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.407B | 28.14 |
| Teladoc Health (TDOC) | United States | $1.239B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.186B | 9.02 |
| Establishment Labs Holdings (ESTA) | $1.061B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| CareDx (CDNA) | United States | $0.971B | 15.16 |
| Agilon Health (AGL) | United States | $0.940B | 0.00 |
| Nutex Health (NUTX) | United States | $0.825B | 12.46 |
| AMN Healthcare Services Inc (AMN) | United States | $0.783B | 7.33 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.620B | 4.18 |
| LifeMD (LFMD) | United States | $0.575B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.548B | 0.00 |
| Enhabit (EHAB) | United States | $0.528B | 43.46 |
| SBC Medicals (SBC) | United States | $0.501B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.491B | 11.07 |
| Sonida Senior Living (SNDA) | United States | $0.465B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.429B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.254B | 0.00 |
| Beauty Health (SKIN) | United States | $0.208B | 0.00 |
| DocGo (DCGO) | United States | $0.151B | 24.67 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| KindlyMD (NAKA) | United States | $0.111B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.094B | 0.00 |
| So-Young (SY) | China | $0.091B | 0.00 |
| OncoCyte (OCX) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.044B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| ModivCare (MODV) | United States | $0.028B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |